Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts

Acta Haematologica

Volumn 101, Issue 2, 1999, Pages 78-81

  Exner, Beate G ^a   Acholonu, Ijeoma N ^a   Bergheim, Marianne ^a   Mueller, Yvonne M ^a   Ildstad, Suzanne T ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b University of Louisville   (United States)

Author keywords

Bone marrow transplantation; Facilitating cell; Mixed allogeneic chimerism; Tolerance

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER; CELL TRANSPLANTATION; CHIMERA; CONFERENCE PAPER; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TOXICITY;

EID: 0032934054     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040928     Document Type: Conference Paper

References (30)

1. Nagano H, Tilney NL: Chronic allograft failure: The clinical problem. Am J Med Sci 1997; 313:305.
2. Billingham RE, Medawar PB: The technique of free skin grafting in mammals. J Exp Biol 1951; 28:385.
3. Billingham RE, Lamphin HG, Medawar PB, Williams HL: Tolerance of homografts, twin diagnosis and the freemartin conditions in cattle. Heredity 1952;6:201.
4. Owen RD: Immunogenic consequences of vascular anastomoses between bovine twins. Science 1945;102:400.
5. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953;172:603.
6. George JF, Sweeney SD, Kirklin JK, Simpson EM, Goldstein DR, Thomas JM: An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 1998;4:333.
7. Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H: Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol 1998;160:2645.
8. Starzl TE, Demetris AJ, Murase N, Ildstad ST, Ricordi C, Trucco M: Cell migration, chimerism and graft acceptance. Lancet 1992;339: 1579.
9. Knobler HY, Sagher U, Peled IJ, Wexler MR, Steiner D, Rubinstein N, Weshler Z, Or R, Slavin S: Tolerance to donor-type skin in the recipient of a bone marrow albgraft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 1985;40:223.
10. Sayegh MH, Fine NA, Smith JL, Rehnke HG, Milford EL, Tilney NL: Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991;114:954.
11. Billingham RE: Reactions of grafts against their hosts: Transplantation immunity works both ways-Hosts destroy grafts and grafts may harm hosts. Science 1959;3381:947.
12. Lampert IA, Janossy G, Suitters AJ, Bofill M, Palmer S, Gordon-Smith E, Prentice HG, Thomas JA: Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol 1982;50:123.
13. Snover DC: Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol 1990; 14(suppl 1):101-108.
14. Beschorner WE, Pino J, Boitnott JK, Tutschka PJ, Santos GW: Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. Am J Pathol 1980;99:369.
15. Deeg HJ, Storb R, Thomas ED: Bone marrow transplantation: A review of delayed complications. Br J Haematol 1984;57:185.
16. Vettenranta K, Hovi L, Parto K, Saarinen-Pihkala UM: Very low-dose methotrexate in the treatment of GVHD in children. Bone Marrow Transplant 1997;20:75.
17. Blazar BR, Taylor PA, Fitzsimmons WE, Vallera DA: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. J Immunol 1994; 153:1836.
18. Blazar BR, Korngold R, Vallera DA: Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 1997;157:79-109.
19. Korngold B, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978;148:1687.
20. Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ, et al: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 1988;3:445.
21. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST: Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow. Blood 1994;84:2436.
22. Ildstad ST, Crilley PA, Shadduck RA, Kaufman CL, Mirrow J, Brodsky I, Brugger W, Gajewski JL, Przepiorka D, Styler MJ, Lister J, Topolsky DL, Manz M, Kanz L, Champlin RL: Graft engineering: The facilitating cell (FC) protocol in HLA mismatched BMT for hematologic malignancy. Blood 1997;90:484.
23. Wood ML, Monaco AP, Gozzo JJ, Liegeois A: Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing. Transplant Proc 1971; 3:676.
24. McCarthy SA, Griffith IJ, Gambel P, Francescutti LH, Wegmann TG: Characterization of host lymphoid cells in antibody-facilitated bone marrow chimeras. Transplantation 1985; 40:12.
25. Cobbold SP, Martin G, Qin S, Waldmann H: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164.
26. Mayumi H, Good RA: The necessity of both allogeneic antigens and stem cells for cyclo-phosphamide-induced skin allograft tolerance in mice. Transplant Proc 1988;20:139.
27. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997;89:3048.
28. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997;3:783.
29. Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST: Durable mixed chimerism and tolerance by a non-lethal radiation-based cytoreductive approach. J Immunol 1996;157: 2820.
30. Exner BG, Colson YL, Li H, Ildstad ST: In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. Surgery 1997;122:221.